Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CHRS Coherus Biosciences

交易中 11-22 15:16:51 EST

1.10

+0.00

-0.45%

最高1.15	最低1.05	成交量209.06万
今开1.09	昨收1.10	日振幅9.09%
总市值1.26亿	流通市值1.13亿	总股本1.15亿
成交额230.64万	换手率2.02%	流通股本1.03亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CHRS","market":"US","secType":"STK","nameCN":"Coherus Biosciences","latestPrice":1.095,"timestamp":1732306582501,"preClose":1.1,"halted":0,"volume":2090622,"delay":0,"floatShares":103303244,"shares":115213407,"eps":-0.003959,"marketStatus":"交易中","marketStatusCode":2,"change":-0.005,"latestTime":"11-22 15:16:51 EST","open":1.09,"high":1.15,"low":1.05,"amount":2306428.7556342003,"amplitude":0.090909,"askPrice":1.1,"askSize":2700,"bidPrice":1.09,"bidSize":4945,"shortable":3,"etf":0,"ttmEps":-0.003959,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":1415250000000,"adjPreClose":1.1,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.09,"preClose":1.1,"latestTime":"09:25 EST","volume":10008,"amount":11071.5211368,"timestamp":1732285553498},"postHourTrading":{"tag":"盘后","latestPrice":1.1197,"preClose":1.1,"latestTime":"19:49 EST","volume":13747,"amount":15188.4527,"timestamp":1732236544005},"volumeRatio":0.538772,"impliedVol":0.3471,"impliedVolPercentile":0.0516},"requestUrl":"/m/hq/s/CHRS","defaultTab":"news","newsList":[{"id":"2485677497","title":"Coherus Biosciences, Inc.盘中异动 股价大跌5.34%报1.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485677497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485677497?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:33","pubTimestamp":1732199611,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时33分，Coherus Biosciences, Inc.股票出现异动，股价快速跳水5.34%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223332a24b761a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223332a24b761a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"gpt_icon":0},{"id":"2484908378","title":"Coherus Biosciences, Inc.盘中异动 急速拉升5.06%报0.821美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484908378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484908378?lang=zh_cn&edition=full","pubTime":"2024-11-20 04:40","pubTimestamp":1732048801,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日04时40分，Coherus Biosciences, Inc.股票出现波动，股价大幅拉升5.06%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.56%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120044002abd00875&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120044002abd00875&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2484967022","title":"Coherus Biosciences, Inc.盘中异动 快速拉升6.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484967022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484967022?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:04","pubTimestamp":1731945849,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日00时04分，Coherus Biosciences, Inc.股票出现异动，股价大幅拉升6.95%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000409971a73a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000409971a73a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2483306492","title":"Coherus Biosciences, Inc.2024财年第三财季实现净利润-10.75百万美元，同比增加72.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306492","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306492?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686420,"startTime":"0","endTime":"0","summary":"11月16日，Coherus Biosciences, Inc.公布财报，公告显示公司2024财年第三财季净利润为-10.75百万美元，同比增加72.88%；其中营业收入为70.77百万美元，同比减少5.10%，每股基本收益为-0.09美元。机构评级：截至2024年11月16日，当前有5家机构对Coherus Biosciences, Inc.目标价做出预测，其中目标均价为6.50美元，其中最低目标价为1.50美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000047abc513a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000047abc513a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS"],"gpt_icon":1},{"id":"2483080623","title":"Coherus Biosciences, Inc.盘中异动 早盘股价大跌5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483080623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483080623?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:09","pubTimestamp":1731683371,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时09分，Coherus Biosciences, Inc.股票出现波动，股价大幅下挫5.49%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.88%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523093198e42f87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523093198e42f87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"gpt_icon":0},{"id":"2483804385","title":"Coherus Biosciences, Inc.盘中异动 早盘快速上涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483804385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483804385?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:31","pubTimestamp":1731594681,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时31分，Coherus Biosciences, Inc.股票出现异动，股价快速上涨5.30%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422312198e42a04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422312198e42a04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2482001081","title":"Coherus Biosciences, Inc.盘中异动 早盘股价大涨5.02%报0.818美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482001081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482001081?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:02","pubTimestamp":1731423768,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日23时02分，Coherus Biosciences, Inc.股票出现波动，股价快速拉升5.02%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112230248abba5d88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112230248abba5d88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2481102927","title":"Coherus Biosciences, Inc.盘中异动 急速跳水5.06%报0.779美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481102927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481102927?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:02","pubTimestamp":1731078126,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时02分，Coherus Biosciences, Inc.股票出现波动，股价快速下挫5.06%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108230207a224d5d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108230207a224d5d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2481567377","title":"Coherus BioSciences Inc    预计每股亏损 12 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481567377","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481567377?lang=zh_cn&edition=full","pubTime":"2024-11-05 07:55","pubTimestamp":1730764509,"startTime":"0","endTime":"0","summary":"   * Coherus BioSciences Inc    将于11月6日公布截至2024年9月30日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，8位分析师的平均预期显示，这家总部位于加利福尼亚州红木城的公司的营收将从去年同期的7457万美元下降20.6%，至5923万美元。* LSEG分析师对Coherus BioSciences Inc的平均预期是每股亏损12美分。* 华尔街对 Coherus BioSciences Inc 的 12 个月目标价中位数为 8.00 美元，高于其最新收盘价 0.67 美元。11月4日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Coherus BioSciences Inc    预计每股亏损 12 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHRS"],"gpt_icon":0},{"id":"2481559324","title":"Coherus Biosciences, Inc.盘中异动 下午盘急速下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481559324","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481559324?lang=zh_cn&edition=full","pubTime":"2024-11-05 04:21","pubTimestamp":1730751719,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日04时21分，Coherus Biosciences, Inc.股票出现波动，股价大幅跳水5.10%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。该公司在美国销售 Neulasta 的生物仿制药，UDENYCA，并预计于 2023 年在美国推出 FDA 批准的 Humira 生物仿制药 YUSIMRY。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110504215998e4058e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110504215998e4058e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2480884402","title":"Coherus BioSciences Inc    预计每股亏损 12 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480884402","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480884402?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:17","pubTimestamp":1730470646,"startTime":"0","endTime":"0","summary":"   * Coherus BioSciences Inc    将于11月6日公布截至2024年9月30日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，8位分析师的平均预期显示，这家总部位于加利福尼亚州红木城的公司的营收将从去年同期的7457万美元下降20.6%，至5923万美元。* LSEG分析师对Coherus BioSciences Inc的平均预期是每股亏损12美分。* 华尔街对 Coherus BioSciences Inc 的 12 个月目标价中位数为 8.00 美元，高于其上次收盘价 0.75 美元。11月1日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Coherus BioSciences Inc    预计每股亏损 12 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHRS"],"gpt_icon":0},{"id":"2479327094","title":"Coherus Biosciences, Inc.盘中异动 快速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479327094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479327094?lang=zh_cn&edition=full","pubTime":"2024-10-29 01:09","pubTimestamp":1730135342,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日01时09分，Coherus Biosciences, Inc.股票出现波动，股价大幅跳水5.06%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029010902ab7c2dae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029010902ab7c2dae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2477568945","title":"Coherus Biosciences, Inc.盘中异动 股价大跌5.28%报0.816美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477568945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477568945?lang=zh_cn&edition=full","pubTime":"2024-10-24 00:26","pubTimestamp":1729700817,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日00时26分，Coherus Biosciences, Inc.股票出现波动，股价急速下挫5.28%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.16%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024002657ab6dd6b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024002657ab6dd6b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2476932632","title":"Coherus Biosciences, Inc.盘中异动 股价大涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476932632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476932632?lang=zh_cn&edition=full","pubTime":"2024-10-19 01:39","pubTimestamp":1729273192,"startTime":"0","endTime":"0","summary":"北京时间2024年10月19日01时39分，Coherus Biosciences, Inc.股票出现波动，股价快速拉升5.59%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101901395398e3d4f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101901395398e3d4f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"gpt_icon":0},{"id":"2475731124","title":"Coherus Biosciences, Inc.盘中异动 股价大跌5.01%报0.941美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475731124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475731124?lang=zh_cn&edition=full","pubTime":"2024-10-15 02:40","pubTimestamp":1728931228,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日02时40分，Coherus Biosciences, Inc.股票出现波动，股价快速下跌5.01%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015024029971a02af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015024029971a02af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2473810497","title":"Coherus Biosciences, Inc.盘中异动 快速上涨5.77%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473810497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473810497?lang=zh_cn&edition=full","pubTime":"2024-10-07 22:52","pubTimestamp":1728312734,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日22时52分，Coherus Biosciences, Inc.股票出现波动，股价大幅拉升5.77%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007225215ab681d0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007225215ab681d0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2472619691","title":"Coherus Biosciences, Inc.盘中异动 股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472619691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472619691?lang=zh_cn&edition=full","pubTime":"2024-10-03 21:57","pubTimestamp":1727963859,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日21时57分，Coherus Biosciences, Inc.股票出现异动，股价急速上涨5.39%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003215740a1de2646&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003215740a1de2646&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2472302919","title":"Coherus Biosciences, Inc.盘中异动 下午盘快速下跌5.21%报0.986美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472302919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472302919?lang=zh_cn&edition=full","pubTime":"2024-10-02 01:24","pubTimestamp":1727803487,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日01时24分，Coherus Biosciences, Inc.股票出现波动，股价大幅跳水5.21%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410020124479719dc1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410020124479719dc1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2470734278","title":"Coherus Biosciences, Inc.盘中异动 早盘急速上涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470734278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470734278?lang=zh_cn&edition=full","pubTime":"2024-09-26 21:46","pubTimestamp":1727358401,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日21时46分，Coherus Biosciences, Inc.股票出现异动，股价快速上涨5.96%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092621464298e391b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092621464298e391b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2468629364","title":"Coherus Biosciences, Inc.盘中异动 股价大跌5.31%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468629364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468629364?lang=zh_cn&edition=full","pubTime":"2024-09-20 21:55","pubTimestamp":1726840522,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日21时55分，Coherus Biosciences, Inc.股票出现波动，股价急速跳水5.31%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.29%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092021552398e38437&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092021552398e38437&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.coherus.com","stockEarnings":[{"period":"1week","weight":0.4238},{"period":"1month","weight":0.277},{"period":"3month","weight":-0.2086},{"period":"6month","weight":-0.4241},{"period":"1year","weight":-0.4554},{"period":"ytd","weight":-0.6697}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Coherus Biosciences, Inc.于2010年9月在特拉华州注册成立。该公司是一家商业阶段的生物制药公司，专注于创新癌症治疗的研究、开发和商业化以及已获批准的生物类似物组合的商业化。该公司的战略是建立一个领先的免疫肿瘤专营权，其资金来自通过净销售美国食品和药物管理局批准的疗法的多元化组合所产生的现金。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.01531},{"month":2,"riseRate":0.5,"avgChangeRate":0.011849},{"month":3,"riseRate":0.5,"avgChangeRate":0.031914},{"month":4,"riseRate":0.5,"avgChangeRate":-0.06174},{"month":5,"riseRate":0.5,"avgChangeRate":-0.005756},{"month":6,"riseRate":0.4,"avgChangeRate":-0.013481},{"month":7,"riseRate":0.5,"avgChangeRate":0.086566},{"month":8,"riseRate":0.8,"avgChangeRate":0.10749},{"month":9,"riseRate":0.1,"avgChangeRate":-0.143671},{"month":10,"riseRate":0.3,"avgChangeRate":-0.071307},{"month":11,"riseRate":0.5,"avgChangeRate":-0.003041},{"month":12,"riseRate":0.5,"avgChangeRate":0.03123}],"exchange":"NASDAQ","name":"Coherus Biosciences","nameEN":"Coherus BioSciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Coherus Biosciences(CHRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Coherus Biosciences,CHRS,Coherus Biosciences股票,Coherus Biosciences股票老虎,Coherus Biosciences股票老虎国际,Coherus Biosciences行情,Coherus Biosciences股票行情,Coherus Biosciences股价,Coherus Biosciences股市,Coherus Biosciences股票价格,Coherus Biosciences股票交易,Coherus Biosciences股票购买,Coherus Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Coherus Biosciences(CHRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}